- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic Targeting of the JAK/STAT Pathway
Authors
Keywords
-
Journal
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
Volume 114, Issue 1, Pages 18-23
Publisher
Wiley
Online
2013-10-24
DOI
10.1111/bcpt.12164
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Janus kinase inhibitors in autoimmune diseases
- (2013) John J O'Shea et al. ANNALS OF THE RHEUMATIC DISEASES
- Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia
- (2013) H. L. M. Rajala et al. BLOOD
- Two Rare Disease-Associated Tyk2 Variants Are Catalytically Impaired but Signaling Competent
- (2013) Z. Li et al. JOURNAL OF IMMUNOLOGY
- STAT Activation in Malignancies: Roles in Tumor Progression and in the Generation of Antineoplastic Effects of IFNs
- (2013) Ben X. Wang et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- JAKs and STATs in Immunity, Immunodeficiency, and Cancer
- (2013) John J. O'Shea et al. NEW ENGLAND JOURNAL OF MEDICINE
- STATs Shape the Active Enhancer Landscape of T Cell Populations
- (2012) Golnaz Vahedi et al. CELL
- JAK and STAT Signaling Molecules in Immunoregulation and Immune-Mediated Disease
- (2012) John J. O'Shea et al. IMMUNITY
- The JAK-STAT Pathway at Twenty
- (2012) George R. Stark et al. IMMUNITY
- A Patient with Tyrosine Kinase 2 Deficiency without Hyper-IgE Syndrome
- (2012) Sara S. Kilic et al. JOURNAL OF PEDIATRICS
- Crystal structures of the JAK2 pseudokinase domain and the pathogenic mutant V617F
- (2012) Rajintha M Bandaranayake et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- SomaticSTAT3Mutations in Large Granular Lymphocytic Leukemia
- (2012) Hanna L.M. Koskela et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mutant JAK3 FERMents ATLL
- (2011) M. Pesu BLOOD
- A Critical Role for STAT3 Transcription Factor Signaling in the Development and Maintenance of Human T Cell Memory
- (2011) Andrea M. Siegel et al. IMMUNITY
- Cytokine Signaling: Birth of a Pathway
- (2011) J. J. O'Shea et al. JOURNAL OF IMMUNOLOGY
- Janus kinase inhibitors for the treatment of myeloproliferative neoplasias and beyond
- (2011) Alfonso Quintás-Cardama et al. NATURE REVIEWS DRUG DISCOVERY
- The pseudokinase domain of JAK2 is a dual-specificity protein kinase that negatively regulates cytokine signaling
- (2011) Daniela Ungureanu et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Anti-inflammatory activity and neutrophil reductions mediated by the JAK1/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritis
- (2010) Debra M Meyer et al. Journal of Inflammation-London
- Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis
- (2010) Srdan Verstovsek et al. NEW ENGLAND JOURNAL OF MEDICINE
- STAT4: Genetics, mechanisms, and implications for autoimmunity
- (2008) Benjamin D. Korman et al. CURRENT ALLERGY AND ASTHMA REPORTS
- Therapeutic targeting of Janus kinases
- (2008) Marko Pesu et al. IMMUNOLOGICAL REVIEWS
- Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome
- (2008) Joshua D. Milner et al. NATURE
- A quantitative analysis of kinase inhibitor selectivity
- (2008) Mazen W Karaman et al. NATURE BIOTECHNOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now